News Agency News Aggregator Journalist/Editor Broking House Others
I have shared my portfolio holdings in the updated edition of my book which will be releasing soon. Replace the microfinance names (Bandhan, Ujjivan, and CreditAccess) and SBI Cards mentioned in it with HDFC Bank, Abbott India, Nestle, and ITC. Rest of the portfolio is unchanged.
#ABBOTINDIA: Abbott India Limited is more expensive today at 52x earnings than it was a week ago at 47x earnings.
#ABBOTINDIA: Abbott India Limited current price of ₹15,210.45 is now higher than the target price of ₹14,392.33.
ABBOTINDIA - Clarification sought from Abbott India Ltd
Abbott India hit all time high of Rs.16869 today and has given 113.11% return in the last 1 year. #stockstowatch #StockMarket
#MarketUpdate: Abbott India sole Nifty 500 stock that touched 52 week high in intraday trade
Abbott India is up 14%
ABBOTT INDIA US Parent Abbott Laboratories Receives Approval For Test That Can Detect CoronaVirus In 5 Minutes To Begin Making Said Tests Available To Healthcare Providers Next Week Plans to supply 50,000 tests/ day starting Apr-1 Expect Positive rub-off on Indian Subsidiary
#ABBOTINDIA: Abbott India Limited has fallen to a 2 star rating. Here is a list of its peers that are 4+ star stocks: ARBN.NS, IPCA.NS, PIRA.NS, NATP.NS, ALEM.NS.
CLSA: Upgrades Cipla from SELL to BUY with a target of Rs480 (from Rs410). Upgrade Lupin from SELL to O-PF with a revised tgt of Rs660 (from Rs600) Top 4 BUY ideas - Sun, Cipla, Cadila and Abbott India.
CLSA on Pharma Pharma earnings relatively secure in a market rife with fear of slowdown Sun Pharma, Cipla, Cadila and Abbott India are Top picks Upgrade Cipla from SELL to BUY TP Rs 480 vs Rs 410 Upgrade LUPIN from SELL to Outperform Revised TP Rs 660 vs Rs 600 @CNBC_Awaaz
#BrokerageRadar | Sun, Cipla, Cadila and Abbott India are our top picks
#ABBOTINDIA: Abbott India Limited's forecast earnings moved 0.0% over the last week, but the price is -11.0%. It's PE ratio is now 45x earnings.
#ABBOTINDIA: Abbott India Limited is cheaper today at 45x earnings than it was a week ago at 50x earnings.
#ABBOTINDIA: Abbott India Limited's price is -11.0% but the forecast earnings moved 0.0% over the last week.
#ABBOTINDIA: Abbott India Limited current price of ₹14,736.8 is now higher than the target price of ₹14,392.33.
#ABBOTINDIA: Abbott India Limited has gained a star, now a 3 star stock.
ITC (Cheap valuation based on reverse DCF; major capex over>>>new 80-85% dividend payout policy) HDFC Bank (Strong market-share capture after the Yes Bank crisis) Bajaj Finance (India's best NBFC company) Abbott India and Nestle (steady, secular growth+free cash flow machines)
#Abbottindia is a case of reversal on D, Strength on D and Momentum on W
Trading Ideas: ABBOTTINDIA - LONG ABOVE 7900 📈 FREE trade-of-week via →